The growth of the market studied is mainly attributed to the rising incidences of cancer and cardiac disorders, widening applications of nuclear medicine, increasing SPECT and PET applications, and increasing patient awareness for healthcare.  According to the 2018 data on cancer from the World Health Organization (WHO), the global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths, in 2018. Moreover, if recent trends in the incidence of major cancers and population growth are consistent, Cancer Research UK predicted that there will be 27.5 million new cancer cases worldwide, each year, by 2040. According to the American Heart Association’s 2019 report, deaths per year due to cardiovascular diseases are expected to increase from 17.9 million in 2016 to 23.6 million in 2030.  The application of nuclear medicine is also widening. Nuclear medicine is used to diagnose and determine the severity of, or, treat a variety of diseases, including the types of cancers, heart diseases, gastrointestinal, endocrine, neurological disorders, and other abnormalities within the body.

1. INTRODUCTION

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

5. MARKET SEGMENTATION

6. COMPANY PROFILES AND COMPETITIVE LANDSCAPE

7. MARKET OPPORTUNITIES AND FUTURE TRENDS